千葉大学大学院医学研究院泌尿器科学・千葉大学医学部附属病院泌尿器科
English サイトマップ HOME
入局・研修をご希望の方 泌尿器科学教室について 患者様用当科診療案内
入局・研修をご希望の方
泌尿器科学教室について
患者様用当科診療案内
共通メニュー
HOME > 泌尿器科学教室について > 教室業績 > 2016年度教室業績
2016年度教室業績
英文原著
1 Goto Y, Kojima S, Kurozumi A, Kato M, Okato A, Matsushita R, Ichikawa T, Seki N. Regulation of E3 ubiquitin ligase-1 (WWP1) by microRNA-452 inhibits cancer cell migration and invasion in prostate cancer. Br J Cancer. 2016 May 10;114(10):1135-44. doi: 10.1038/bjc.2016.95. Epub 2016 Apr 12. PubMed PMID:27070713; PubMed Central PMCID: PMC4865980.
2 Okato A, Goto Y, Kurozumi A, Kato M, Kojima S, Matsushita R, Yonemori M, Miyamoto K, Ichikawa T, Seki N. Direct regulation of LAMP1 by tumor-suppressive microRNA-320a in prostate cancer. Int J Oncol. 2016 Jul;49(1):111-22. doi:10.3892/ijo.2016.3522. Epub 2016 May 16. PubMed PMID: 27212625; PubMed Central PMCID: PMC4902064.
3 Takei A, Sazuka T, Nakamura K, Nihei N, Ichikawa T. Port-site transversus abdominis fascia closure reduced the incidence of incisional hernia following retroperitoneal laparoscopic nephrectomy. Hernia. 2016 Oct;20(5):735-40. doi:10.1007/s10029-016-1508-4. Epub 2016 May 26. PubMed PMID: 27229940.
4 Kato M, Kurozumi A, Goto Y, Matsushita R, Okato A, Nishikawa R, Fukumoto I,Koshizuka K, Ichikawa T, Seki N. Regulation of metastasis-promoting LOXL2 gene expression by antitumor microRNAs in prostate cancer. J Hum Genet. 2017 Jan;62(1):123-132. doi: 10.1038/jhg.2016.68. Epub 2016 Jun 9. PubMed PMID:27278788.
5 Imamura Y, Sadar MD. Androgen receptor targeted therapies in castration-resistant prostate cancer: Bench to clinic. Int J Urol. 2016 Aug;23(8):654-65. doi: 10.1111/iju.13137. Review. PubMed PMID: 27302572.Epub 2016 Jun 14
6 Kamiya N, Suzuki H, Suyama T, Kobayashi M, Fukasawa S, Sekita N, Mikami K,Nihei N, Naya Y, Ichikawa T. Clinical outcomes of second transurethral resection in non-muscle invasive high-grade bladder cancer: a retrospective,multi-institutional, collaborative study. Int J Clin Oncol. 2017 Apr;22(2):353-358. doi: 10.1007/s10147-016-1048-z. Epub 2016 Oct 15. PubMed PMID:27744487.
7 Fujimura M, Sakamoto S, Sekita N, Takeuchi N, Nishikawa R, Suzuki H, Mikami K,Ichikawa T. Apparent diffusion coefficient value for estimating clinicohistological factors in bladder cancer including infiltration style and lymphatic invasion. Springerplus. 2016 Jun 23;5(1):848. oi:10.1186/s40064-016-2504-y. eCollection 2016. PubMed PMID: 27386297; PubMed Central PMCID: PMC4919192.
8 Goto Y, Kurozumi A, Nohata N, Kojima S, Matsushita R, Yoshino H, Yamazaki K,Ishida Y, Ichikawa T, Naya Y, Seki N. The microRNA signature of atients with sunitinib failure: regulation of UHRF1 pathways by microRNA-101 in renal cell carcinoma. Oncotarget. 2016 Sep 13;7(37):59070-59086. doi:10.18632/oncotarget.10887. PubMed PMID: 27487138; PubMed Central PMCID:PMC5312296.
9 Namekawa T, Utsumi T, Tanaka T, Kaga M, Nagano H, Kono T, Kawamura K, Kamiya N, Imamoto T, Suzuki H, Ichikawa T. Hypertension Cure Following Laparoscopic Adrenalectomy for Hyperaldosteronism is not Universal: Trends Over Two Decades.World J Surg. 2017 Apr;41(4):986-990. doi: 10.1007/s00268-016-3822-5. PubMed PMID: 27872977.
10 Kei Yoneda, Shinichi Sakamoto, Akinori Takei, Miki Fuse, Koji Kawamura, Takashi Imamoto, Hiroyoshi Suzuki and Tomohiko Ichikawa, An unusual foreign body in the urethra,Received date: Jul 14, 2016
Accepted date: Aug 12, 2016,Published date: Aug 18, 2016
11 Banuelos CA, Tavakoli I, Tien AH, Caley DP, Mawji NR, Li Z, Wang J, Yang YC,Imamura Y, Yan L, Wen JG, Andersen RJ, Sadar MD. Sintokamide A Is a Novel Antagonist of Androgen Receptor That Uniquely Binds Activation Function-1 in Its Amino-terminal Domain. J Biol Chem. 2016 Oct 14;291(42):22231-22243. PubMed PMID:27576691; PubMed Central PMCID: PMC5064002.Epub 2016 Aug 30
12 Imamura Y, Tien AH, Pan J, Leung JK, Banuelos CA, Jian K, Wang J, Mawji NR, Fernandez JG, Lin KS, Andersen RJ, Sadar MD.: An imaging agent to detect androgen receptor and its active splice variants in prostate cancer. JCI Insight. 2016 Jul 21;1(11). pii: e87850.PMID: 27525313 PMCID: PMC4980083 DOI: 10.1172/jci.insight.87850
13 Amiya Y, Yamada Y, Sugiura M, Sasaki M, Shima T, Suzuki N, Nakatsu H, Murakami S, Shimazaki J. Treatment of locally advanced prostate cancer (Stage T3). Jpn J Clin Oncol. 2017 Mar 1;47(3):257-261. doi: 10.1093/jjco/hyw186. PubMed PMID:28096182.
14 Y Amiya .Y Yamada .M Sugiura .M sasaki .T Shima .N Suzuki ,H Nakatsu ,S Murakami J Shimazaki Outcomes of patient older than75 years with non- metastatic prostate cancer.Asian J urol 2017,2:102-106,doi Accepted 2 December 2016,Available online 3 January ,doi:10.1016/j.ajur.2016.12.001.
15 Yamada Y, Sakamoto S, Shimazaki J, Sugiura M, Amiya Y, Sasaki M, Shima T, Komiya A, Suzuki N, Akakura K, Ichikawa T, Nakatsu H. Significant Prognostic Difference between Grade Group 4 and 5 in the 2014 International Society of Urological Pathology (ISUP) Grading System for High Grade Prostate Cancer with Bone Metastasis. Prostate Int. 10.1016/j.prnil.2017.03.001
16 Kurozumi A, Goto Y, Okato A, Ichikawa T, Seki N. Aberrantly expressed microRNAs in bladder cancer and renal cell carcinoma. J Hum Genet. 2017 Jan;62(1):49-56. doi: 10.1038/jhg.2016.84. Epub 2016 Jun 30. Review. PubMed PMID:27357429.
症例治験手技
1 Namekawa T, Utsumi T, Imamoto T, Kawamura K, Oide T, Tanaka T, Nihei N, Suzuki H, Nakatani Y, Ichikawa T. Composite pheochromocytoma with a malignant peripheral nerve sheath tumor: Case report and review of the literature. Asian J Surg. 2016 Jul;39(3):187-90. doi: 10.1016/j.asjsur.2012.11.003. Epub 2013 Feb 20. PubMed PMID: 27338175.
2 Yoneda K, Sakamoto S, Takei A, Fuse M, Kawamura K, Imamoto T, et al. An unusual foreign body in the urethra. SM J Urol. 2016; 2(1): 1017.
総説
1 Kurozumi A, Goto Y, Okato A, Ichikawa T, Seki N. Aberrantly expressed microRNAs in bladder cancer and renal cell carcinoma. J Hum Genet. 2017 Jan;62(1):49-56. doi: 10.1038/jhg.2016.84. Epub 2016 Jun 30. Review. PubMed PMID:27357429.
このページの先頭へ



一つ前のページへ戻る このページの先頭へ HOMEに戻る
copyright(C). Department of Urology. Graduate School of Medicine. Chiba University. All Rights Reserved.